Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Pediatr Blood Cancer. 2016 May 16;63(9):1608–1614. doi: 10.1002/pbc.26061

Figure 1.

Figure 1

Cumulative incidence curve for the development of late toxicities following intensity modulated radiation therapy (IMRT) for head and neck rhabdomyosarcoma in pediatric patients.